Professional Documents
Culture Documents
COLLEGE OF SCIENCE
DEPARTMENT OF NURSING
Awarded Level III Status by the Accrediting Agency of Chartered Colleges and Universities in the Philippines
ATRIAL FIBRILLATION
N AbN
General Appearance
Posture
Hygiene/Grooming
Nutrition/Diet
Body Size/Habitus
/ The patient is oversized.
Height:
Weight:
IBW: ___________
BMI: 35.6 / The patient is obese.
IRS: ____________
Behavior
/ Fatigue, light headedness, and weak.
LOC
Vital Signs
Temperature: ℃
Rhythm: irregular
Rhythm:
___________
Skin
/ The patient is pale due to low blood pressure.
Color
Temperature
/ Cold, clammy skin
Turgor
Texture
Integrity
Unusual Marks
Rashes, Lesions
Site:
___________________
Site: _______
Type: _____
Size/Degree: _____
Hair
Texture
Thickness
Hygiene Status
Nails
Hygiene Status
Presence of Clubbing
Head
Unusual swelling
Cranial bruit
N AbN
Eyes
Cornea
Pupils
Size (mm)
PERRLA
Visual Acuity
Orbital Bruit
Other Findings:
________________
Ear
Location/Alignment
Pinna, Cannals,
Drums
Hygiene
Hearing Acuity
Tinnitus
Vertigo/Dizziness
Other Findings:
______
Nose
Shape
Symmetry
Patency
Mucosal Integrity
Epistaxis
Sinuses
Other Findings:
______
Lips
Integrity
Symmetry
Color
/ Pale color of the lips.
Other Findings: _
Mouth
Hygiene
Gums
Mucosal Integrity
Tongue
Tonsils
Palate
Parotid Gland
Hoarseness
Other Findings:
Neck
Carotid Bruit
Neck Veins
Thyroid
Trachea
Rigidity/Tenderness
Mass/Bruises
Other
Findings:_______
Mass/Lump
Others:__________
N AbN
Breathing
Spontaneity
With Ventilator
With Tracheostomy
Rhythm
/ Tachypneic
Depth
Effort
Cough
Amount: _____________
Consistency: __________
Color: _______________
Odor: _______________
a. Bronchial
b. Crackles
c. Rhonci
d. Wheezes
e. Stridor
f. Crepitus
CTT
Location: __________
Suction: ___________
Quality of Drainage:
___________
ABG
Other Findings:
________________
Heart
History
/ Feeling of flip -flops, skips beat like its banging
against the chest walls.
With Palpitation
Rhythm
of heart) Specify:
a. Heaves
b. Clicks
c. Splitting
d. Thrills
e. Callops
f. Muffles
a. S1
b. S2
c. S3
d. S4
Murmurs
a. Systolic
b. Diastolic
N AbN
Abdomen
Diet: ____________________
Umbilicus Protrusion
LUQ: __________
RUQ: __________
LLQ: __________
RLQ: __________
Abdominal Bruit
Distention
Nausea
Vomitus/Hematemesis
Amount: _______________
Consistency: ____________
Color: _________________
Odor: _________________
Frequency: _____________
Drainage Tube
Abdominal Mass
Abdominal Girth: __________
Other Findings:
________________
Back
Spine
Paralumbar
Other Findings:
________________
Genitalia
Symmetry
Presence of Tenderness
Urethral Discharge
Bleeding
Pelvic Pain
LMP: ________________
With Dysuria
Nocturia
History of Impotence
Urinalysis Finding:
_____________
a. Date Started
b. Incorporation
c. Cycle Exchange
Amount: _______________
Dwell Time: ____________
Drainage Time: __________
d. PD Return
Color: __________
Hemodialysis
Frequency:
________________
Last HD:
__________________
Next HD:
__________________
Place:
____________________
Form No.: TSU-COS- Revision No.: Effectivity Date: June 22,
Page 4 of 6
SF- 00 2016
N AbN
Rectal Examination
Anal Inspection
Location: ______________
Mass
Characteristic of Stool:
__________
Other Findings:
________________
Nodes
Lymphadenopathy
Location
Others ______________
Extremity
Texture
Capillary Refill
/ Capillary refill less than 3 seconds.
Carotid
Radial
Ulna
Brachial
Femoral
Posterior Tibial
Dorsalis Pedis
Popliteal
Clubbing of Fingers
Varicosities
Thrombophlebitis
Cyanosis
/ Cyanotic nails and oral mucosa
Joints
Erythema
Tenderness
Deformity
Swelling
Muscles
Bulk
Tone
Tenderness
Ulcerations
Edema
Other Findings:
________________
Form No.: TSU-COS- Revision No.: Effectivity Date: June 22, Page 5 of 6
SF- 00 2016
N AbN
Hematopoietic
Easy Bruisability
Excessive Bleeding
Anticoagulants
Bleeding Profile
Anemia
Hematology Report
Other Findings:
________________
Neurology
CN I (Olfactory)
CN II (Optic)
CN III (Oculomotor)
CN IV (Trochlear)
CN V (Trigeminal)
CN VI (Abducens)
CN VII (Facial)
CN VIII (Vestibulocochlear)
CN IX (Glossopharyngeal)
CN X (Vagus)
CN XI (Spinal Accessory)
CN XII (Hypoglossal)
Motor and Posture
Sensory Perception
Reflexes
Other Findings:
_________________
Patient’s ADL
a. Bathing
b. Dressing
c. Elimination
d. Mobility and Movement
e. Nutrition and Feeding
Form No.: TSU-COS-SF- Revision No.: 00 Effectivity Date: June 22, 2016 Page 6 of 6
TARLAC STATE UNIVERSITY
COLLEGE OF SCIENCE
DEPARTMENT OF NURSING
Awarded Level III Status by the Accrediting Agency of Chartered Colleges and Universities in the Philippines
Subjective: Decreased Cardiac After 5 days of rendering Independent After 8 hours of nursing
Output related to altered appropriate nursing intervention, the clients
“My heart flip – flops, electrical conduction as intervention the patient Monitor vital to determine verbalized improved fluid
skips beats, and feels like evidence by irregular will maintain cardiac signs regularly. changes in the volume as evidenced by:
it’s banging against my heart rhythm. output as evidenced by patient’s
chest wall, especially if heart rate, blood pressure, condition.
I’m carrying stuff up my respiratory rate, and level
stairs or bending down of consciousness within - Increased urine
and I was nauseated, light normal ranges. output from 14
– headed, and weak. I had Monitor client’s To note changes into 19mL/hr
really fast heartbeat and intake and output. in renal status.
felt like I was gasping for - Decreased pitting
air.” As verbalized by the edema from grade
client. Assess ECG 2+ into grade 1+
changes such as To monitor bipedal edema.
widening of the reoccurrence of
QRS, - Increased blood
arrythmias
Objective: prolongation of pressure from
the QT interval, 76/44 into 80/60
GCS: 10 increased heart mmHg
rate.
Irregular heart - Normal
rhythm respiratory rate 20
Chest pain Demonstrate and bpm
encourage use of
Vital Signs: stress Promotes patient
management participation in
Temperature: 36.1 behaviors, exerting some
℃ relaxation
sense of control in
Pulse Rate: 137 techniques,
guided imagery, a stressful
cpm situation.
slow/deep
Respiration Rate: breathing.
23bpm
- No visible P Dependent
waves
Assist in
- Wide QRS with cardioversion
right bundle To manage
branch block articular
pattern. fibrillation.
Provide oxygen
therapy as
indicated.
Oxygen is
administered to
increase the
amount of oxygen
carried by
available
Insert and hemoglobin in the
maintain blood.
intravenous
access.
Medication
therapy is more
effective when
initiated early.
TARLAC STATE UNIVERSITY
COLLEGE OF SCIENCE
DEPARTMENT OF NURSING
Awarded Level III Status by the Accrediting Agency of Chartered Colleges and Universities in the Philippines
SOAPIE CHARTING
S - “My heart flip – flops, skips beats, and feels like it’s banging against my chest wall,
especially if I’m carrying stuff up my stairs or bending down and I was nauseated, light –
headed, and weak. I had really fast heartbeat and felt like I was gasping for air.” As verbalized
by the client.
O-
GCS: 10
Irregular heart rhythm
Chest pain
Vital Signs:
Temperature: 36.1 ℃
Pulse Rate: 137 cpm
Respiration Rate: 23bpm
Blood Pressure: 80/50 mmHg
Laboratory Results:
ECG:
No visible P waves
Wide QRS with right bundle branch block pattern.
Inclusive
Year Level RLE Group dates of
Rotation
Name of
Patien B Age 75 y/o Gender Male
Patient
- Limit food intake and avoid salty, fatty, and high sugar level
foods.
Date Signed
Date Submitted
NAME OF DRUG MECHANISM OF INDICATION SIDE EFFECTS NURSING RESPONSIBILITIES
ACTION
GENERIC NAME: Control ventricular Dizziness, headache,
Digoxin Inhibits response rate in diarrhea, rash, visual Baseline assessment
sodium/potassium patients with disturbances. Assess apical pulse. If pulse is 60 or less/min
BRAND NAME: ATPase pump in chronic atrial (70 or less/min for children), withhold drug,
Lanoxin myocardial cells. fibrillation. contact physician. Blood samples are best
Promotes calcium taken 6–8 hrs. after dose or just before next
influx. Increases dose.
CLASSIFICATION: effective refractory Intervention/evaluation
Cardiac glycoside, period/decreases Monitor pulse for bradycardia, EKG for
Antiarrhythmic conduction velocity, arrhythmias for 1–2 hrs after administration
decreases heart rate. (excessive slowing of pulse may be first
clinical sign of toxicity). Assess for GI
disturbances, neurologic abnormalities (signs
of toxicity) q2–4h during loading dose (daily
during maintenance). Monitor serum
potassium, magnesium, calcium, renal
function. Therapeutic serum level: 0.8–2
ng/mL; toxic serum level: greater than 2
ng/mL
NAME OF DRUG MECHANISM OF INDICATION SIDE EFFECTS NURSING RESPONSIBILITIES
ACTION
GENERIC NAME: treatment of Occasional: GI
Warfarin Interferes with hepatic thromboembolic distress (nausea, Baseline assessment
synthesis of vitamin disorders and anorexia, abdominal Cross-check dose with co-worker. Obtain
BRAND NAME: K–dependent clotting embolic cramps, diarrhea). CBC, PT/INR before administration and daily
Coumadin factors, resulting in complications Rare: following therapy initiation. When
depletion of coagulation arising from atrial Hypersensitivity stabilized, follow with INR determination
factors II, VII, IX, X. fibrillation reaction (dermatitis, q4–6wks. Obtain genotyping prior to
CLASSIFICATION: Prevents further urticaria), esp. in those initiating therapy if available. Screen for
Anticoagulant extension of formed sensitive to aspirin. major active bleeding. Question recent history
existing clot; prevents of bleeding, recent trauma, surgical
new clot formation, procedures, epidural anesthesia.
secondary
thromboembolic Intervention/evaluation
complications. Monitor INR diligently. Assess CBC for
anemia; urine/stool for occult blood. Be alert
to complaints of abdominal/back pain,
severe headache, confusion, seizures,
hemiparesis, aphasia (may be sign of
hemorrhage). Decrease in B/P, increase in
pulse rate may be sign of hemorrhage.
Question for increase in amount of
menstrual discharge. Assess peripheral pulses;
skin for ecchymoses, petechiae. Check for
excessive bleeding from minor cuts,
scratches. Assess gums for erythema, gingival
bleeding.
Patient/family teaching
Take medication at same time each
day.
Blood levels will be monitored
routinely.
Do not take, discontinue any other
medication except on advice of
physician.
Avoid alcohol, aspirin, drastic dietary
changes.
Consult with physician before surgery,
dental work.
Urine may become red orange.
Falls, subtle injuries, esp. head or
abdominal trauma, can be life-
threatening.
Report bleeding, bruising, red or
brown urine, black stools.
Use electric razor, soft toothbrush to
prevent bleeding.
Report coffee-ground vomitus, blood-
tinged mucus from cough.
Do not use any OTC medication
without physician approval (may
interfere with platelet aggregation).
Seek immediate medical attention for
stroke-like symptoms (confusion,
difficulty speaking, headache, one-
sided weakness); bloody stool or urine.
NAME OF DRUG MECHANISM OF INDICATION SIDE EFFECTS NURSING RESPONSIBILITIES
ACTION
GENERIC NAME: treatment of severe Occasional (5%–3%):
Norepinephrine Stimulates beta1- hypotension Anxiety, bradycardia, Baseline assessment
adrenergic receptors, palpitations. Assess EKG, B/P continuously (be alert to
BRAND NAME: alpha-adrenergic Rare (2%–1%): precipitous B/P drop). Be alert to patient
Levophed receptors, increasing Nausea, anginal pain, complaint of headache.
contractility, heart rate shortness of breath, Intervention/evaluation
CLASSIFICATION: and producing fever. Monitor IV flow rate diligently. Assess for
Vasopressor vasoconstriction. extravasation characterized by blanching of
Increases systemic B/P, skin over vein, coolness (results from local
coronary blood flow. vasoconstriction); color, temperature of IV
site extremity (pallor, cyanosis, mottling).
Assess nail bed capillary refill. Monitor
I&O; measure output hourly, report urine
output less than 30 mL/hr. Once B/P
parameter has been reached, IV infusion
should not be started unless systolic B/P falls
below 90 mm Hg.